Category: Biomarkers and Laboratory Measurements
Surrogate Endpoint
A measurement used in place of a direct clinical outcome because it is expected to predict a meaningful benefit. In DMD, dystrophin measurements may be considered in this context, but an increase in a surrogate marker does not automatically establish improved mobility, quality of life, or survival.
- Updated November 3, 2026